Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.91B |
| 2 |
SPCX
SpaceX
SPCX
|
+$871M |
| 3 |
Eli Lilly
LLY
|
+$719M |
| 4 |
Amazon
AMZN
|
+$698M |
| 5 |
Netflix
NFLX
|
+$627M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$3B |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.54B |
| 3 |
TSMC
TSM
|
+$1.42B |
| 4 |
NVIDIA
NVDA
|
+$1.41B |
| 5 |
SNDK
Sandisk
SNDK
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.67% |
| 2 | Technology | 3.92% |
| 3 | Healthcare | 2.55% |
| 4 | Industrials | 2.24% |
| 5 | Financials | 2.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3726
Myriad Genetics
MYGN
$383M
| $8.76M | ﹤0.01% |
1,533,684
+1,080,642
| +239% | +$4.91M |
|
3727
Iovance Biotherapeutics
IOVA
$4.55B
| $8.76M | ﹤0.01% |
2,104,990
-506,355
| -19% | -$1.92M |
|
|
SA
3728
Seabridge Gold
SA
$3.34B
| $8.75M | ﹤0.01% |
340,107
-464,700
| -58% | -$14M |
|
3729
PUT
GXO Logistics
GXO
$5.24B
| $8.75M | ﹤0.01% |
172,600
+111,100
| +181% | +$5.75M |
|
3730
CALL
Sanofi
SNY
$102B
| $8.75M | ﹤0.01% |
205,100
+22,900
| +13% | +$1.02M |
|
3731
Vestis
VSTS
$1.82B
| $8.75M | ﹤0.01% |
602,562
-357,640
| -37% | -$3.99M |
|
3732
PUT
Acuity Brands
AYI
$9.01B
| $8.74M | ﹤0.01% |
23,200
+5,600
| +32% | +$1.66M |
|
3733
CALL
Adeia
ADEA
$2.71B
| $8.74M | ﹤0.01% |
265,300
+164,000
| +162% | +$4.84M |
|
3734
CALL
Expeditors International
EXPD
$24.5B
| $8.74M | ﹤0.01% |
53,600
+21,100
| +65% | +$3.26M |
|
3735
International Flavors & Fragrances
IFF
$21.2B
| $8.72M | ﹤0.01% |
110,109
-992,404
| -90% | -$73.9M |
|
|
NB
3736
NioCorp Developments
NB
$518M
| $8.72M | ﹤0.01% |
1,809,673
-4,394,524
| -71% | -$24.1M |
|
3737
PUT
Dynatrace
DT
$15.9B
| $8.72M | ﹤0.01% |
198,600
+109,400
| +123% | +$4.26M |
|
|
BBT
3738
Beacon Financial Corp
BBT
$2.58B
| $8.71M | ﹤0.01% |
286,141
+126,907
| +80% | +$3.8M |
|
3739
CALL
Penske Automotive Group
PAG
$13.9B
| $8.7M | ﹤0.01% |
48,600
+29,900
| +160% | +$5M |
|
3740
Replimune Group
REPL
$1.23B
| $8.68M | ﹤0.01% |
784,233
+385,504
| +97% | +$2.36M |
|
3741
Energy Fuels
UUUU
$3.11B
| $8.67M | ﹤0.01% |
597,641
+313,930
| +111% | +$5.77M |
|
3742
Blend Labs
BLND
$289M
| $8.66M | ﹤0.01% |
5,062,868
+370,351
| +8% | +$591K |
|
3743
Establishment Labs
ESTA
$2.08B
| $8.65M | ﹤0.01% |
100,838
-448,449
| -82% | -$32.2M |
|
3744
PUT
SentinelOne
S
$7.86B
| $8.65M | ﹤0.01% |
509,500
+33,500
| +7% | +$515K |
|
3745
Boston Beer
SAM
$1.77B
| $8.64M | ﹤0.01% |
48,829
-4,385
| -8% | -$889K |
|
3746
Metallus
MTUS
$782M
| $8.64M | ﹤0.01% |
462,261
+227,940
| +97% | +$4.28M |
|
3747
PUT
Under Armour
UAA
$2.13B
| $8.64M | ﹤0.01% |
1,351,700
-83,100
| -6% | -$493K |
|
|
RERE
3748
ATRenew
RERE
$870M
| $8.63M | ﹤0.01% |
+2,230,500
| New | +$9.9M |
|
|
SAIL
3749
SailPoint Inc
SAIL
$11.3B
| $8.62M | ﹤0.01% |
589,042
-4,461,948
| -88% | -$60.8M |
|
3750
Gibraltar Industries
ROCK
$1.26B
| $8.62M | ﹤0.01% |
191,107
+72,658
| +61% | +$2.85M |
|
Similar funds
Citadel Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Citadel Advisors held 15,445 positions worth $875B, up 41% from $618B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q2 2026 filing shows 2,573 new, 6,088 increased, 4,803 reduced and 1,873 closed positions. Its largest new stake was SpaceX: 5,129,884 shares worth $876M. The largest sale was Micron Technology, an estimated $3B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 79% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q2 2026 buy was SpaceX: 5,129,884 shares worth $876M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.91B increase.
- Citadel Advisors's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $3B.
- Citadel Advisors fully exited iShares 7-10 Year Treasury Bond ETF in Q2 2026, selling an estimated $325M.
- Citadel Advisors's ten largest holdings make up 23% of its $875B portfolio in Q2 2026.
- Citadel Advisors opened 2,573 new positions and closed 1,873 in Q2 2026.
- Citadel Advisors's portfolio value rose 41% quarter-over-quarter to $875B.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.